Yan Lin

7.2k total citations
227 papers, 5.2k citations indexed

About

Yan Lin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yan Lin has authored 227 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 71 papers in Oncology and 51 papers in Immunology. Recurrent topics in Yan Lin's work include Cancer Immunotherapy and Biomarkers (35 papers), Immunotherapy and Immune Responses (26 papers) and RNA modifications and cancer (17 papers). Yan Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (35 papers), Immunotherapy and Immune Responses (26 papers) and RNA modifications and cancer (17 papers). Yan Lin collaborates with scholars based in China, United States and Japan. Yan Lin's co-authors include John M. Kirkwood, Rong Liang, Ahmad A. Tarhini, Cindy Sander, Lisa H. Butterfield, Jiazhou Ye, Jinyan Zhang, Zhihui Liu, Lianjie Lin and Yongqiang Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yan Lin

224 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Lin China 37 2.3k 1.7k 1.3k 1.3k 618 227 5.2k
Takeshi Nagashima Japan 37 3.0k 1.3× 1.2k 0.7× 1.1k 0.9× 1.3k 1.0× 569 0.9× 208 6.2k
Alexander Arlt Germany 42 2.9k 1.3× 1.6k 0.9× 1.2k 1.0× 1.2k 0.9× 544 0.9× 131 5.6k
Yun Zhang China 40 3.8k 1.7× 1.9k 1.1× 1.2k 1.0× 2.1k 1.7× 757 1.2× 257 7.2k
Yanyan Li China 40 4.0k 1.8× 1.7k 1.0× 759 0.6× 1.6k 1.3× 671 1.1× 265 6.5k
Dean Tian China 40 2.8k 1.2× 1.1k 0.6× 1.0k 0.8× 1.4k 1.1× 567 0.9× 183 5.2k
Shoichi Hazama Japan 40 1.7k 0.8× 2.1k 1.3× 1.2k 0.9× 725 0.6× 579 0.9× 187 4.5k
John J. Arcaroli United States 35 1.9k 0.9× 1.3k 0.8× 1.5k 1.2× 1.0k 0.8× 945 1.5× 76 5.0k
Luigi Marchionni United States 41 2.7k 1.2× 1.6k 0.9× 595 0.5× 1.4k 1.1× 933 1.5× 136 5.1k
Fei Ye United States 44 2.5k 1.1× 1.7k 1.0× 521 0.4× 1.2k 1.0× 745 1.2× 209 5.4k
Shan Zeng China 46 2.8k 1.2× 1.9k 1.2× 1.7k 1.4× 1.2k 1.0× 1.3k 2.0× 286 7.4k

Countries citing papers authored by Yan Lin

Since Specialization
Citations

This map shows the geographic impact of Yan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Lin more than expected).

Fields of papers citing papers by Yan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Lin. The network helps show where Yan Lin may publish in the future.

Co-authorship network of co-authors of Yan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Lin. A scholar is included among the top collaborators of Yan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Lin. Yan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hongyang, Dandan Zeng, Rong Liang, et al.. (2025). Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 2407–2419.
2.
Lin, Yan, et al.. (2024). Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity. Journal of Pediatric Endocrinology and Metabolism. 37(7). 605–612. 1 indexed citations
3.
Brose, Marcia S., Bruce Robinson, Lori J. Wirth, et al.. (2024). Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC).. Journal of Clinical Oncology. 42(16_suppl). 11111–11111. 3 indexed citations
4.
Lü, Zhan, Ye Tao, Zhibo Chen, et al.. (2024). Gut commensal Agathobacter rectalis alleviates microglia-mediated neuroinflammation against pathogenesis of Alzheimer disease. iScience. 27(11). 111116–111116. 11 indexed citations
5.
Gao, Xing, Cheng Lü, Ziyu Liu, et al.. (2023). RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5. Cancers. 15(11). 2897–2897. 4 indexed citations
6.
Ye, Jiazhou, Ziyu Liu, Xing Gao, et al.. (2021). Eukaryotic Initiation Factor 4A-3: A Review of Its Physiological Role and Involvement in Oncogenesis. Frontiers in Oncology. 11. 712045–712045. 39 indexed citations
7.
Liang, Rong, Jinyan Zhang, Zhihui Liu, et al.. (2021). Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 585452–585452. 15 indexed citations
9.
Lin, Yan, et al.. (2020). RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer. OncoTargets and Therapy. Volume 13. 13225–13236. 8 indexed citations
10.
Xie, Mingzhi, Yufeng Lv, Zhihui Liu, et al.. (2018). Identification and validation of a four-miRNA(miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma. Cancer Management and Research. Volume 10. 5759–5766. 28 indexed citations
11.
Fang, Wenqian, Aina He, Meixiang Xiang, et al.. (2018). Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. Journal of Molecular and Cellular Cardiology. 127. 44–56. 24 indexed citations
12.
Sobo-Vujanovic, Andrea, Lazar Vujanović, Albert B. DeLeo, et al.. (2016). Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice. Cancer Immunology Research. 4(5). 441–451. 29 indexed citations
13.
Gyanchandani, Rekha, Yan Lin, Hui‐Min Lin, et al.. (2016). Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer. Clinical Cancer Research. 22(21). 5362–5369. 53 indexed citations
14.
Zhang, Ying, Jin Yu, Yan Lin, et al.. (2015). Adipose-Derived Mesenchymal Stem Cells Ameliorate Ulcerative Colitis Through miR-1236 Negatively Regulating the Expression of Retinoid-Related Orphan Receptor Gamma. DNA and Cell Biology. 34(10). 618–625. 19 indexed citations
15.
Vlad, Anda, Gina Mantia-Smaldone, Robin Laskey, et al.. (2013). Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer. Clinical Cancer Research. 19(5). 1213–1224. 158 indexed citations
16.
Jin, Yu, Yan Lin, Lianjie Lin, & Chang-Qing Zheng. (2012). IL-17/IFN-γ Interactions Regulate Intestinal Inflammation in TNBS-Induced Acute Colitis. Journal of Interferon & Cytokine Research. 32(11). 548–556. 38 indexed citations
19.
Mohamed, Mahfuzah, Suresh S. Ramalingam, Yan Lin, William E. Gooding, & Chandra P. Belani. (2005). Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer. Annals of Oncology. 16(5). 780–785. 71 indexed citations
20.
Lin, Yan & Marek J. Drużdżel. (1998). Relevance-Based Sequential Evidence Processing in Bayesian Networks. The Florida AI Research Society. 446–450. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026